Heart Outcomes Prevention and Evaluation 4
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1438 participants.
Also called NCT01826019
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose health services research
- Phase
- Phase 4
- Enrolled
- 1,438 participants
- Sponsor
- Registry
-
NCT01826019
-
- Other papers using this trial's data
- A community-based comprehensive intervention to reduce cardiovascular risk in hypertension (HOPE 4): a cluster-randomised controlled trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Canada, Colombia, Malaysia
- Registry status
- Completed
Technical summary
Registry record NCT01826019. Randomized; no masking; primary purpose health services research. Start 2014-08 (actual); primary completion 2019-02 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Heart Outcomes Prevention and Evaluation 4
- Acronym
- HOPE-4
- Condition
- Hypertension
- Condition
- Cardiovascular Disease
- Intervention (Other)
- Intervention
- Intervention (Other)
- Usual Care
- Lead sponsor
- Hamilton Health Sciences Corporation
- Collaborator
- Population Health Research Institute
- Collaborator
- Canadian Institutes of Health Research (CIHR)
- Collaborator
- Grand Challenges Canada
- Collaborator
- Global Alliance for Chronic Diseases (GACD)
Record details
- Record id
cardio:ct-nct01826019- Content hash
9b14b0b1d343f8b21c8051b6bb7bd776345be250fc4a8906aaec39becf7ccb31